{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:22:52Z","timestamp":1788906172535,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:00:00Z","timestamp":1569024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Apolipoprotein-\u03b54 (APOE-\u03b54)\u2014common variant is a major genetic risk factor for cognitive decline and Alzheimer's disease (AD). An accelerated rate of biological aging could contribute to this increased risk. Glycation of serum proteins due to excessive glucose and reactive oxygen species leads to the formation of advanced glycation end products (AGEs)\u2014a risk factor for diabetes and AD, and decline in motor functioning in elderly adults. Aim of present study was to investigate impact of APOE-\u03b54 allele containing genotype and accumulation of AGEs in plasma on telomere length (TL). Results showed that TL is significantly shorter in APOE-\u03b54 carriers compared with non-APOE-\u03b54 carriers (p = .0003). Higher plasma glucose level was associated with shorter TL irrespective of APOE-\u03b54 allele containing genotype (r = \u2212.26; p = .0004). With regard to AGEs, higher plasma glyoxal and fluorescent AGEs concentrations were inversely related to TL (r = \u2212.16; p = .03; r = \u2212.28; p = .0001), however, plasma N\u03b5-(carboxymethyl)lysine levels didn't correlate with TL (r = \u2212.04; p = .57). Results support the hypotheses that APOE-\u03b54 carriers have shorter telomeres than noncarriers and telomere erosion is increased with higher concentration of glucose, fluorescent AGEs, and glyoxal.<\/jats:p>","DOI":"10.1093\/gerona\/glz203","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T02:21:26Z","timestamp":1569032486000},"page":"1894-1898","source":"Crossref","is-referenced-by-count":13,"title":["Shorter Telomere Length in Carriers of APOE-\u03b54 and High Plasma Concentration of Glucose, Glyoxal and Other Advanced Glycation End Products (AGEs)"],"prefix":"10.1093","volume":"75","author":[{"given":"Varinderpal S","family":"Dhillon","sequence":"first","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6477-9127","authenticated-orcid":false,"given":"Permal","family":"Deo","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Chua","sequence":"additional","affiliation":[{"name":"Student and Academic Services, University of South Australia, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Thomas","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fenech","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Adelaide, Australia"},{"name":"Genome Health Foundation, North Brighton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,21]]},"reference":[{"key":"2020092513344426300_CIT0001","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3233\/JAD-180303","article-title":"Lifetime risk factors for functional and cognitive outcomes in patients with Alzheimer's disease","volume":"65","author":"de Oliveira","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2020092513344426300_CIT0002","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"2020092513344426300_CIT0003","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/mp.2013.194","article-title":"APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms","volume":"19","author":"Conejero-Goldberg","year":"2014","journal-title":"Mol Psychiatry"},{"key":"2020092513344426300_CIT0004","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics7040542","article-title":"Genomic discoveries and personalized medicine in neurological diseases","volume":"7","author":"Zhang","year":"2015","journal-title":"Pharmaceutics"},{"key":"2020092513344426300_CIT0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"2020092513344426300_CIT0006","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1474-4422(15)00323-3","article-title":"Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study","volume":"15","author":"Jack","year":"2016","journal-title":"Lancet Neurol"},{"key":"2020092513344426300_CIT0007","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"2020092513344426300_CIT0008","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jbt.20301","article-title":"Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein","volume":"23","author":"Deo","year":"2009","journal-title":"J Biochem Mol Toxicol"},{"key":"2020092513344426300_CIT0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(97)00266-8","article-title":"Enhanced binding of advanced glycation endproducts (AGE) by the APOE4 isoform links the mechanism of plaque deposition in Alzheimer's disease","volume":"226","author":"Li","year":"1997","journal-title":"Neurosci Lett"},{"key":"2020092513344426300_CIT0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/CCLM.2011.079","article-title":"Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease","volume":"49","author":"Rahmadi","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"2020092513344426300_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.02.018","article-title":"Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective","volume":"317","author":"Li","year":"2012","journal-title":"J Neurol Sci"},{"key":"2020092513344426300_CIT0012","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00394-016-1212-2","article-title":"Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders","volume":"55","author":"Stefano","year":"2016","journal-title":"Eur J Nutr"},{"key":"2020092513344426300_CIT0013","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2017","journal-title":"Redox Biol"},{"key":"2020092513344426300_CIT0014","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.febslet.2004.11.036","article-title":"Telomeres and telomerase: their mechanisms of action and the effects of altering their functions","volume":"579","author":"Blackburn","year":"2005","journal-title":"FEBS Lett"},{"key":"2020092513344426300_CIT0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/nar\/gki273","article-title":"Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2","volume":"33","author":"Opresko","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2020092513344426300_CIT0016","doi-asserted-by":"crossref","first-page":"e17837","DOI":"10.1371\/journal.pone.0017837","article-title":"Leukocyte telomere length in major depression: correlations with chronicity, in\ufb02ammation and oxidative stress\u2014preliminary \ufb01ndings","volume":"6","author":"Wolkowitz","year":"2011","journal-title":"PLoS One"},{"key":"2020092513344426300_CIT0017","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1038\/s41598-018-36344-w","article-title":"AKF-PD alleviates diabetic nephropathy via blocking the RAGE\/AGEs\/NOX and PKC\/NOX pathways","volume":"9","author":"Qin","year":"2019","journal-title":"Sci Rep"},{"key":"2020092513344426300_CIT0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.neurobiolaging.2010.03.004","article-title":"APOE \u03b54 is associated with longer telomeres, and longer telomeres among \u03b54 carriers predicts worse episodic memory","volume":"33","author":"Wikgren","year":"2012","journal-title":"Neurobiol Aging"},{"key":"2020092513344426300_CIT0019","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10654-015-0051-4","article-title":"Increased attrition of leukocyte telomere length in young adults is associated with poorer cognitive function in midlife","volume":"31","author":"Cohen-Manheim","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2020092513344426300_CIT0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.exger.2017.08.025","article-title":"Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients","volume":"98","author":"Scarabino","year":"2017","journal-title":"Exp Gerontol"},{"key":"2020092513344426300_CIT0021","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/gerona\/glr185","article-title":"Association between ApoE phenotypes and telomere erosion in Alzheimer's disease","volume":"67","author":"Takata","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2020092513344426300_CIT0022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajp.2014.06.012","article-title":"Reduced telomere length in subjects with dementia and diabetes mellitus type 2 is independent of apolipoprotein E4 genotype","volume":"12","author":"Kota","year":"2014","journal-title":"Asian J Psychiatr"},{"key":"2020092513344426300_CIT0023","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.mad.2008.09.020","article-title":"Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish Mental Survey","volume":"129","author":"Starr","year":"2018","journal-title":"Mech Ageing Dev"},{"key":"2020092513344426300_CIT0024","doi-asserted-by":"crossref","first-page":"e54713","DOI":"10.1371\/journal.pone.0054713","article-title":"Accelerated cell aging in female APOE-\u03b54 carriers: implications for hormone therapy use","volume":"8","author":"Jacobs","year":"2013","journal-title":"PLoS One"},{"key":"2020092513344426300_CIT0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-801816-3.00010-8","article-title":"Telomere, ageing and nutrition.","volume-title":"Molecular Basis of Nutrition and Ageing","author":"Dhillon","year":"2016"},{"key":"2020092513344426300_CIT0026","doi-asserted-by":"crossref","first-page":"e23145","DOI":"10.1002\/ajhb.23145","article-title":"Lifetime socioeconomic status and early life microbial environments predict adult blood telomere length in the Philippines","volume":"30","author":"Tennyson","year":"2018","journal-title":"Am J Hum Biol"},{"key":"2020092513344426300_CIT0027","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-019-03503-0","article-title":"Hyperglycaemia cause vascular inflammation through advanced glycation end products\/early growth response-1 axis in gestational diabetes mellitus","volume":"456","author":"Rajaraman","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"2020092513344426300_CIT0028","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/carcin\/bgy012","article-title":"Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer","volume":"39","author":"Rojas","year":"2018","journal-title":"Carcinogenesis"},{"key":"2020092513344426300_CIT0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-032918-021921","article-title":"Shelterin-mediated telomere protection","volume":"52","author":"de Lange","year":"2018","journal-title":"Annu Rev Genet"},{"key":"2020092513344426300_CIT0030","doi-asserted-by":"crossref","first-page":"e12487","DOI":"10.1111\/micc.12487","article-title":"The role of senescence, telomere dysfunction and shelterin in vascular aging","volume":"26","author":"Liu","year":"2019","journal-title":"Microcirculation"},{"key":"2020092513344426300_CIT0031","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1017\/S0029665108006988","article-title":"Genome-health nutrigenomics and nutrigenetics: nutritional requirements or \u2018nutriomes' for chromosomal stability and telomere maintenance at the individual level","volume":"67","author":"Bull","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"2020092513344426300_CIT0032","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11556-008-0032-7","article-title":"Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity","volume":"5","author":"Magalhaes","year":"2008","journal-title":"Eur Rev Aging Phys Act"},{"key":"2020092513344426300_CIT0033","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/nu8030125","article-title":"Dietary advanced glycation end products and risk factors for chronic disease: a systematic review of randomised controlled trials","volume":"8","author":"Clarke","year":"2016","journal-title":"Nutrients"}],"container-title":["The Journals of Gerontology: Series A"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glz203\/30107213\/glz203.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/75\/10\/1894\/33792817\/glz203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/75\/10\/1894\/33792817\/glz203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:35:14Z","timestamp":1601055314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/75\/10\/1894\/5572352"}},"subtitle":[],"editor":[{"given":"Rozalyn","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,21]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,21]]},"published-print":{"date-parts":[[2020,9,25]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glz203","relation":{},"ISSN":["1079-5006","1758-535X"],"issn-type":[{"value":"1079-5006","type":"print"},{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2019,9,21]]}}}